FDA DEVICE FACTS
aprevo® cervical interbody system
Carlsmed, Inc.
Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。
Indications for use
The aprevo® cervical ACDF interbody system includes interbody fusion devices indicated at one or more levels of the cervical spine (C2- T1) in pa Ɵents with cervical disc disease, instability, trauma including fractures, deformity defined as kyphosis, lordosis, or scoliosis, cervical spondyloƟc myelopathy, spinal stenosis, and failed previous fusion. Cervical disc disease is defined as discogenic pain with degenera Ɵon of the disc confirmed by history and radiographic studies. These pa Ɵents should be skele tally mature and have had at least six (6) weeks of non-operaƟve treatment. The devices are to be filled with autograŌ bone and/or allogenic bone graŌ comprised of cancellous, cor Ɵcal, and/or cor Ɵcocancellous bone. The aprevo® cervical ACDF interbody system must be used with supplemental fixa Ɵon (e.g., cervical plate or cervical posterior fixaƟon). aprevo® cervical ACDF-X interbody system The aprevo® cervical ACDF-X interbody system includes interbody fusion devices indicated at one or more levels of the cervical spine (C2- T1) in pa Ɵents with cervical disc disease, instability, trauma including fractures, deformity defined as kyphosis, lordosis, or scoliosis, cervical spondyloƟc myelopathy, spinal stenosis, and failed previous fusion. Cervical disc disease is defined as discogenic pain with degenera Ɵon of the disc confirmed by history and radiographic studies. These pa Ɵents should be ske letally mature and have had at least six (6) weeks of non-operaƟve treatment. The devices are to be filled with autograŌ bone and/or allogenic bone graŌ comprised of cancellous, corƟcal, and/or corƟcocancellous bone. When used with the screws that accompany the device, the aprevo® cervical ACDF-X interbody system is intended for use as a standalone system. Deformity procedures to correct coronal angulaƟon or use of a hyperlordoƟc device (>20° lordosis) must include supplemental fixaƟon (e.g., cervical plate or cervical posterior fixaƟon).
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。